ReviewTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2026
Platelet Products and Artificial Platelets for Regenerative Medicine.
Review in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Background: Platelet products derived from whole blood include platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet lysate (PL), and platelet-derived extracellular vesicles (pEVs). Such products have been utilized for hemostatic purposes and regenerative medicine. Poor shelf life, high cost of storage, immune risk, and constant need for adequate donors have led to the desire for biomaterials that mimic platelet function. Artificial platelets, such as platelet-membrane coated nanoparticles (NPs), platelet-like particles, SynthoPlate, and GRGDS-PEG-coated polyurethane NPs, have been designed to mimic platelet functionality and aid in hemostasis. Summary: Platelet product and artificial platelet function can be further leveraged for regenerative medicine and wound healing as they interact with activated platelets and fibrin at the region of interest, highlighting their therapeutic potential. Example regenerative applications of both platelet products and artificial platelets include osteogenesis, angiogenesis, soft tissue and dermal healing, and drug or cell delivery. Key Messages: Some platelet products have reached clinical trials, but most of the biomaterial based approaches are still in preclinical testing. Research into their regenerative and wound healing capabilities is novel for the field, but the products show tremendous promise in biomedical applications beyond hemostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.